Status: current, Defined. Date: 31-Oct 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4470851000168114 | Hapa Pharm CBD 50 (CBD 50:THC 0.2) (cannabidiol 50 mg / 1 mL + delta-9-tetrahydrocannabinol less than 0.2%) oral oil, 60 mL, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4470861000168111 | Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | Is a | Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL | true | Inferred relationship | Some | ||
| Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | has TP | Hapa Pharm CBD 50 (CBD 50:THC 0.2) | true | Inferred relationship | Some | ||
| Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil, 60 mL, bottle | has TPUU | Hapa Pharm CBD 50 (CBD 50:THC 0.2) oral oil | true | Inferred relationship | Some | 1408891595 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Schedule 8 medications reference set
Australian dialect reference set
Description inactivation indicator reference set
Containered trade product pack reference set
FHIR